Gene Bridges and BASF Sign Collaboration Agreement
News Apr 18, 2007
Gene Bridges GmbH, the recombineering company announced that it has signed a collaboration agreement with BASF AG to use Gene Bridges’ Red/ET recombination technology alongside BASF´s expertise in biotechnology, process development and product application.
Under the terms of the agreement, Gene Bridges will provide bio-molecular engineering for strain optimisation and in return, BASF will be responsible for subsequent screening and product and process development. The new agreement is a significant expansion of previous service projects carried out by Gene Bridges for BASF.
“We are delighted to have reached this agreement with such a major player in the industrial biotechnology sector as BASF,” commented Dr. Harald Kranz, who is jointly responsible for this project at Gene Bridges GmbH.
Dr. Tim Zeppenfeld, who shares responsibility for the project at Gene Bridges GmbH, added: “We feel confident that our know-how combined with BASF´s excellent technical possibilities will result in a significant acceleration of strain development.”
Genome-wide association studies (GWAS) look at large populations to find genes that contribute to common, multi-gene traits like height or obesity. These comprehensive studies frequently turn up large numbers of tiny genetic variations that occur more often in people who are tall, obese, etc. So which genes should scientists investigate further?READ MORE
In recent years, numerous studies have shown that people who don't get enough sleep are at greater risk of stroke and heart attack. A study found that people who sleep fewer than 7 hours per night have lower blood levels of three physiological regulators, or microRNAs, which influence gene expression and play a key role in maintaining vascular health.